Literature DB >> 26232454

Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.

Patricia López1, Javier Rodríguez-Carrio2, Aleida Martínez-Zapico2, Luis Caminal-Montero2, Ana Suarez2.   

Abstract

The chronic inflammatory environment associated with systemic lupus erythematosus can lead to an accelerated immunosenescence responsible for the endothelial damage and increased cardiovascular risk observed in these patients. The present study analyzed two populations with opposite effects on vascular endothelium, angiogenic T cells and the senescent CD4(+)CD28(null) subset, in 84 systemic lupus erythematosus patients and 46 healthy controls. Also, 48 rheumatoid arthritis patients and 72 individuals with traditional cardiovascular risk factors participated as disease controls. Phenotypic characterization of CD28(+) and CD28(null) cells was performed by analyzing markers of senescence (CCR7, CD27, CD57) and cytotoxicity (CD56, perforin, granzyme B, IFN-γ). IL-1β, IL-6, IL-8, IL-10, IL-12, IL-17A, IFN-α, IFN-γ, TNF-α, B lymphocyte stimulator, and GM-CSF serum levels were analyzed in systemic lupus erythematosus patients and healthy controls. CD4(+)CD28(null) cells were notably increased in the systemic lupus erythematosus patients and disease controls compared with healthy controls. In contrast, angiogenic T cells were only reduced in the disease controls (those with rheumatoid arthritis or traditional cardiovascular risk factors). Nevertheless, an anomalous presence of CD28(null)-angiogenic T cells, with cytotoxic and senescent characteristics, was noted in systemic lupus erythematosus patients in association with anti-dsDNA titer, anti-SSA/Ro antibodies and circulating TNF-α, IL-8, IFN-α, and B lymphocyte stimulator amounts. This subset was also detected in those with traditional cardiovascular risk factors but not in the rheumatoid arthritis patients. In contrast, CD28(+)-angiogenic T cells were reduced in the systemic lupus erythematosus patients with cardiovascular disorders. In conclusion, CD28 expression must be used to redefine the angiogenic T cell population, because in pathologic conditions, a senescent CD28(null)-angiogenic T cell subset with inflammatory, rather than protective, effects could be present. © Society for Leukocyte Biology.

Entities:  

Keywords:  BLyS; CD4+CD28null; IFN-α; Tang cells; cardiovascular disease

Mesh:

Substances:

Year:  2015        PMID: 26232454     DOI: 10.1189/jlb.5HI0215-042R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

1.  DUSP23 is over-expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients.

Authors:  E Balada; L Felip; J Ordi-Ros; M Vilardell-Tarrés
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

Review 2.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

3.  Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.

Authors:  Mirko Manetti; Sara Pratesi; Eloisa Romano; Silvia Bellando-Randone; Irene Rosa; Serena Guiducci; Bianca Saveria Fioretto; Lidia Ibba-Manneschi; Enrico Maggi; Marco Matucci-Cerinic
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

4.  Mycophenolic acid induces senescence of vascular precursor cells.

Authors:  Ellen Go; Stefan P Tarnawsky; W Chris Shelley; Kimihiko Banno; Yang Lin; Chang-Hyun Gil; Emily K Blue; Laura S Haneline; Kathleen M O'Neil; Mervin C Yoder
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

5.  Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase-4 inhibitor Linagliptin: A subanalysis from a randomized, placebo-controlled trial (RELEASE study).

Authors:  Stefanie A de Boer; Melanie Reijrink; Wayel H Abdulahad; Elisa S Hoekstra; Riemer H J A Slart; Hiddo J L Heerspink; Johanna Westra; Douwe J Mulder
Journal:  Diabetes Obes Metab       Date:  2020-03-27       Impact factor: 6.577

6.  The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis.

Authors:  Dimitrios Chanouzas; Michael Sagmeister; Lovesh Dyall; Phoebe Sharp; Lucy Powley; Serena Johal; Jessica Bowen; Peter Nightingale; Charles J Ferro; Matthew D Morgan; Paul Moss; Lorraine Harper
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

7.  Premature Senescence of T-cells Favors Bone Loss During Osteolytic Diseases. A New Concern in the Osteoimmunology Arena.

Authors:  Luis González-Osuna; Alfredo Sierra-Cristancho; Carolina Rojas; Emilio A Cafferata; Samanta Melgar-Rodríguez; Angélica M Cárdenas; Rolando Vernal
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

8.  Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.

Authors:  Jinlin Miao; Feng Qiu; Tingting Li; Peng Zhao; Kui Zhang; Minghua Lv; Jun Wan; Xiaokun Qi; Ping Zhu
Journal:  Mediators Inflamm       Date:  2016-03-15       Impact factor: 4.711

9.  Older men display elevated levels of senescence-associated exercise-responsive CD28null angiogenic T cells compared with younger men.

Authors:  Mark Ross; Lesley Ingram; Guy Taylor; Eva Malone; Richard J Simpson; Dan West; Geraint Florida-James
Journal:  Physiol Rep       Date:  2018-06

10.  Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients.

Authors:  Peng Zhao; Jinlin Miao; Kui Zhang; Minghua Lv; Qing Han; Ping Zhu
Journal:  Med Sci Monit       Date:  2018-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.